Oncology Ventures
Venture Capital Exempt reporting adviser
Legal name: Oncology Ventures LLC
AUM
$80.7M
Private fund assets
Private funds
11
Venture Capital 11
Private fund assets
$80.7M
Gross asset value
Employees
—
Last Form D raise
May 2024
Most recent fund filing
From SEC Form ADV filing (filed Feb 25, 2026). View on SEC
People(1)
Owners and executive officers named on the firm's SEC Form ADV.
B
Funds(11)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Oncology Ventures Fund I LP | Venture Capital | $25.4M | $21.2M | 69 | May 2024 | Cold |
| Oncology Ventures Fund I-A LP | Venture Capital | $7.0M | $5.0M | 37 | May 2024 | Cold |
| Health Universe Dec 2023, A Series of Cgf2021 LLC | Venture Capital | $246K | $246K | 7 | Feb 2024 | Cold |
| Concr Jun 2023 A Series of Cgf2021 LLC | Venture Capital | $411K | $411K | 17 | Oct 2023 | Cold |
| Vivor Care Jan 2023, A Series of Cgf2021 LLC | Venture Capital | $278K | $278K | 30 | Feb 2023 | Cold |
| Oncology Ventures Fund II LP | Venture Capital | $37.1M | — | — | — | |
| Oncology Ventures Fund Ii-A LP | Venture Capital | $9.1M | — | — | — | |
| Risa Nov 2024, A Series of Cgf2021 LLC | Venture Capital | $481K | — | — | — | |
| Risa Series A Nov 2025 Series of Cgf2021 LLC | Venture Capital | $363K | — | — | — | |
| Tono Health Nov 2024, A Series of Cgf2021 LLC | Venture Capital | $261K | — | — | — | |
| Nexcure Nov 2025, A Series of Cgf2021 LLC | Venture Capital | $145K | — | — | — |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 334395
- SEC file number
- 802-132161
Sources
- SEC Form ADV Oct 14, 2026